News
Recruitment for RATIONALE will begin at the NCT in 2025. The study is investigating the benefits of molecularly controlled treatment for patients with rare cancers. The researchers want to prove that the progression-free survival of patients with advanced rare cancers can be doubled compared to standard therapy. For the first time, all six NCT sites are pooling their joint expertise in a study involving patients throughout Germany.
Researchers from Dresden want to bring sensors that have so far only been used in quantum computing and communication to the operating room. An EU grant totaling EUR 5 million over four years is supporting the consortium in developing and implementing this technology.
In December, Forbes magazine named Dr. Fiona Kolbinger one of the most influential young scientists on its famous “30 under 30 North America 2025” list. With her research at the interface between surgery, data science and computer science, Kolbinger is developing pioneering AI methods for improved treatment in difficult operations.
A research alliance from Cambridge (Great Britain), Daejeon (South Korea) and Dresden is working to shed some light on the origin of clonal pathogenesis with the joint project "ClonEScape". For this project, the scientists Prof. Benjamin Simons (University of Cambridge), Dr. Maria Alcolea (University of Cambridge), Dr. Bon-Kyoung Koo (Institute for Basic Science) and Prof. Daniel Stange (TU Dresden) have been awarded the prestigious Synergy Grant of the European Research Council (ERC) alongside funding amounting to almost EUR 10M.
Digitalization is playing an increasingly important role in laboratories as well. The use of artificial intelligence in data analysis significantly expands possibilities in the areas of diagnostics and individualized therapies. Therefore, the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) awards the Digital Laboratory Funding Prize for outstanding scientific achievements.
18.09.2024: Biochemist Oliver Bruns (NCT/UCC Dresden) and chemist Ellen Sletten (UCLA) have been presented with the Helmholtz High Impact Award 2024 by the Helmholtz Association and the “Stifterverband für die Deutsche Wissenschaft” for their research into an innovative medical imaging technology in the short-wave infrared range. The procedure they have developed has the potential to significantly improve surgical removal of tumors. At yesterday’s award ceremony in Berlin, the two scientists were presented with the award – endowed with € 50,000 – in recognition of their interdisciplinary research.
30.08.2024: An international group of scientists led by Prof. Oliver Bruns (NCT/UCC Dresden), Dr. Andriy Chmyrov (NCT/UCC Dresden), Prof. Ellen Sletten (UCLA) and Prof. Christopher Rowlands (Imperial College London) has once again received renowned funding from the Chan Zuckerberg Initiative. With their research, the team strives to improve imaging in deeper tissue layers.